Study of AntiCTLA4 in Patients With Unresectable or Metastatic Uveal Melanoma
Clinical trial NCT01034787 · COMPLETED
Trial details
- NCT number
- NCT01034787
- Sponsor
- AHS Cancer Control Alberta
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-17
- Primary completion
- 2017-08-08
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.